Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:31PM EDT. Market open.
| Previous close | 27.85 |
| Open | 28.32 |
| Bid | 28.37 x 800 |
| Ask | 28.39 x 800 |
| Day's range | 27.58 - 28.59 |
| 52-week range | 18.21 - 58.00 |
| Volume | |
| Avg. volume | 973,725 |
| Market cap | 3.762B |
| Beta (5Y monthly) | -0.41 |
| PE ratio (TTM) | 3.22 |
| EPS (TTM) | 8.82 |
| Earnings date | 02 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 54.83 |
- Zacks
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of -241.18% and 129.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Avidity Biosciences, Inc. (RNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Avidity Biosciences, Inc. (RNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool
3 Fast-Growing Stocks to Buy Now
It's really exciting to see triple-digit revenue growth. ShockWave Medical (NASDAQ: SWAV) and BioCryst Pharmaceuticals (NASDAQ: BCRX) are blowing the roof off right now, with 194% and 162% sales increases, respectively.
© 2022 Yahoo. All rights reserved.
